FDA Webinar: Draft GFI On Expedited Programs For Serious Conditions Drugs And Biologics - August 5, 2013

On August 5, 2013, FDA presented a webinar on a new draft guidance entitled "Draft Guidance For Industry On Expedited Programs For Serious Conditions Drugs And Biologics."

The webinar provided an opportunity to learn about the guidance from individuals involved in its preparation. It was also intended to encourage the submission of questions or comments while the guidance is still in draft form.
Questions may be submitted to docket so that they can be formally processed by FDA.

Docket No. FDA-2013-D-0575 which can be found at: www.regulations.gov

Date FR NOA: 06/26/2013

Comment Period Closes: 08/26/2013
Stephanie Shapley
Health Science Policy Analyst
Office of Medical Policy
Brutrinia Cain
Regulatory Counsel
Office of Medical Policy

Archive of Past Webinars: http://www.fda.gov/Training/GuidanceWebinars/default.htm

If you have never attended a Connect Pro meeting before, please test your connection before the lecture by following this link: https://collaboration.fda.gov/common/help/en/support/meeting_test.htm

More in Drugs

Resources for You

Page Last Updated: 10/08/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English